Back to results
US 8,008,093 B2Granted
Inhibition of Hsp27 phosphorylation for the treatment of blistering disorders
AssigneeThe University of North Carolina at Chapel Hill
InventorsDavid Scott Rubenstein, Paula Berkowitz, Peiqi Hu, Luis Alberto Diaz
Life of this patent
Estimating the term…
Abstract
A method of treating a blistering disorder, which includes administering to a target tissue in a subject in need thereof an effective amount of a composition that inhibits activation of the HSP27 phosphorylation pathway.
Claims13
A method of treating a blistering disorder, comprising:
- a) providing a subject suffering from a blistering disorder, wherein the blistering disorder is an autoimmune blistering disorder;
- and
- b) administering to a target tissue in the subject an effective amount of a composition that inhibits activation of a HSP27 phosphorylation pathway in the target tissue.
Dependencies are inferred from the claim text.